Ipca Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019, to consider and approve the Audited Financial Results for the 4th quarter and financial year ended 31st March, 2019; and recommendation of dividend for the said financial year.
The above information is a part of company’s filings submitted to BSE.